Lymphoma Drugs Market Research Reports

Global Lymphoma Partnering 2012 to 2018 - Product Thumbnail Image

Global Lymphoma Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Global Non-Hodgkin Lymphoma Partnering 2012 to 2018 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Non-Hodgkin Lymphoma - Heat Map and Analysis - Product Thumbnail Image

Non-Hodgkin Lymphoma - Heat Map and Analysis

  • Drug Pipelines
  • 15 Pages
From
CAS 936563-96-1 PCI-32765 Chemical World Report - Product Thumbnail Image

CAS 936563-96-1 PCI-32765 Chemical World Report

  • Report
  • 2069 Pages
CAS 23214-92-8 Adriamycin Chemical World Report - Product Thumbnail Image

CAS 23214-92-8 Adriamycin Chemical World Report

  • Report
  • 2153 Pages
Non-Hodgkin Lymphoma Pipeline Highlights - 2018 - Product Thumbnail Image

Non-Hodgkin Lymphoma Pipeline Highlights - 2018

  • Report
From
Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2018 - Product Thumbnail Image

Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2018

  • Report
From
Europe Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2018 - Product Thumbnail Image

Europe Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2018

  • Report
From
Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024 - Product Thumbnail Image

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • Report
  • 280 Pages
From
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018

  • Report
  • 498 Pages
From
Global Hodgkin's Lymphoma Treatment Market - Segmented by Treatment Type and Geography - Growth, Trends and Forecasts (2018 - 2023) - Product Thumbnail Image

Global Hodgkin's Lymphoma Treatment Market - Segmented by Treatment Type and Geography - Growth, Trends and Forecasts (2018 - 2023)

  • Report
  • 108 Pages
From
Global Non-Hodgkin Lymphoma Therapeutics Market - Segmented by Type of Treatment - Growth, Trends and Forecasts (2018 - 2023) - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Therapeutics Market - Segmented by Type of Treatment - Growth, Trends and Forecasts (2018 - 2023)

  • Report
  • 110 Pages
From
Cutaneous T-Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecasts to 2027 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecasts to 2027

  • Drug Pipelines
  • 154 Pages
From
Global and Chinese L-Asparaginase Industry - 2018 - Product Thumbnail Image

Global and Chinese L-Asparaginase Industry - 2018

  • Report
  • 140 Pages
From
Global and Chinese Asparaginase Industry - 2018 - Product Thumbnail Image

Global and Chinese Asparaginase Industry - 2018

  • Report
  • 150 Pages
From
Global and Chinese Ibrutinib Industry - 2018 - Product Thumbnail Image

Global and Chinese Ibrutinib Industry - 2018

  • Report
  • 138 Pages
From
Anti-Lymphotoxin -Pipeline Insight, 2018 - Product Thumbnail Image

Anti-Lymphotoxin -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Mycosis Fungoides - Pipeline Insight, 2018 - Product Thumbnail Image

Mycosis Fungoides - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 - Product Thumbnail Image

Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018

  • Drug Pipelines
  • 60 Pages
From
Treanda - Drug Insight, 2018 - Product Thumbnail Image

Treanda - Drug Insight, 2018

  • Drug Pipelines
  • 35 Pages
From
Loading Indicator

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

adroll